Anti-tumor peptide AP25 decreases cyclin D1 expression and inhibits MGC-803 proliferation via phospho-extracellular signal-regulated kinase-, Src-, c-Jun N-terminal kinase-and phosphoinositide 3-kinase-associated pathways
Jialiang Hu(China Pharmaceutical University), Hanmei Xu(China Pharmaceutical University)
Cited by 8
Related Papers
Prospects for chimeric antigen receptor-modified T cell therapy for solid tumors
|Molecular Cancer|2018|99
Micropeptide MIAC inhibits the tumor progression by interacting with AQP2 and inhibiting EREG/EGFR signaling in renal cell carcinoma
|Molecular Cancer|2022|79
Novel production method of innovative antiangiogenic and antitumor small peptides in <em>Escherichia coli</em>
|Drug Design Development and Therapy|2017|9